Key Strategies Adopted by Key Players in the Astaxanthin Market

The Astaxanthin Market is projected to reach USD 965 million by 2026, from USD 647 million in 2021, at a CAGR of 8.3% during the forecast period.

Astaxanthin is recognized as the most powerful antioxidant in nature, wherein according to a 2019 report by NCBI, astaxanthin has established its benefits as a vital nutrient for human consumption. Its unique structure helps it to scavenge free radicals and protect the body against oxidative damage. Therefore, it is called super antioxidant. Apart from imparting antioxidant properties, astaxanthin is also beneficial to the eyes, heart, and skin, and has anti-cancer, anti-inflammatory, and anti-diabetic properties. Some of the key factors driving the growth of astaxanthin across the globe include beneficial effects on the healthcare sector, the growth of the end-user industries, and rising innovative technology developments for the extraction of astaxanthin.

Download PDF Brochure

Key players in this market include BASF SE, Otsuka Holdings Co. Ltd., Koninklijke DSM N.V., Divi’s Laboratories Ltd., and Cyanotech Corporation.

Koninklijke DSM N.V., also called Royal DSM, is a science-based company engaged in the health, nutrition, and materials business. The company operates through four segments: nutrition, materials, innovation center, and corporate activities. Its nutrition segment includes DSM Nutritional Products and DSM Food Specialties. The company’s nutrition and food ingredients segment caters to different end-use application industries such as food, feed, and pharmaceuticals. It offers nutraceutical ingredient products for dietary supplements and the food beverages industry. Being one of the leaders in vitamins, carotenoids, nutraceuticals, and premixes, DSM has entered the astaxanthin industry with innovative products for both human and animal nutrition.

BASF SE is one of the leading chemical companies and is listed on stock exchanges in Frankfurt (Germany), London (UK), and Zurich (Switzerland). The company has 11 divisions grouped into six segments: chemicals, materials, industrial solutions, surface technologies, nutrition care, and agricultural solutions. For financial reporting, it has organized its regional divisions into four regions: Europe, North America, Asia Pacific, and South America/Africa/Middle East. The nutrition care segment offers a comprehensive range of products across human nutrition, animal nutrition, pharma solutions, and aroma ingredients. BASF is one of the strongest suppliers of vitamins, antioxidants, and carotenoids for the human nutrition business supplying to all major companies in the pharma, nutraceutical, beverage, and dietary supplement industries.

Make an Inquiry

Otsuka Holdings Co. Ltd. is a manufacturer of pharmaceuticals; clinical testing equipment; and medical devices and equipment, food, and cosmetic products. The company operates through four segments: pharmaceuticals, nutraceuticals, consumer products, and other businesses. The pharmaceutical business entails prescription drugs, while the nutraceutical business encompasses nutritional food beverages and cosmetics. It offers astaxanthin through its nutraceutical business segment. Otsuka Pharmaceutical Co., Ltd. is a subsidiary of Otsuka Holdings Co. Ltd.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

The Astaxanthin Market is projected to reach USD 965 million by 2026, from USD 647 million in 2021, at a CAGR of 8.3% during the forecast period. Astaxanthin is recognized as the most powerful antioxidant in nature, wherein according to a 2019 report by NCBI, astaxanthin has established its benefits as a vital nutrient for…

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.